Solution chemistry and Mössbauer study of iron(II) and iron(III) complexes from gallocyanine

Kenneth T. Douglas; Brendan Howlin; Jack Silver

doi:10.1016/S0020-1693(00)80010-9

Solution chemistry and Mössbauer study of iron(II) and iron(III) complexes from gallocyanine

Kenneth T. Douglas, Brendan Howlin, Jack Silver^*

^*Corresponding author for this work

Pharmacy

The University of Essex

Research output: Contribution to journal › Article › peer-review

Abstract

The iron solution chemistry of the FeCl₃-gallocyanine system has been investigated by pH titration, UV visible spectroscopy and Mössbauer spectroscopy. Iron reduction was found in the pH range 2-5 and photo-reduction of the iron(III) present was also noted. Due to the instability of the species present in solution, the use of gallocyanine as a spectrophotometric indicator in iron systems is not encouraged. The iron-gallocyanine system was proposed as a potential model of the photosensitive anti-cancer drug, Bleomycin.

Original language	English
Pages (from-to)	135-140
Number of pages	6
Journal	Inorganica Chimica Acta
Volume	92
Issue number	2
DOIs	https://doi.org/10.1016/S0020-1693(00)80010-9
Publication status	Published - Jun 1984

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0020-1693(00)80010-9

Cite this

@article{2becfb76cf1a44f58561134e991b25ac,

title = "Solution chemistry and M{\"o}ssbauer study of iron(II) and iron(III) complexes from gallocyanine",

abstract = "The iron solution chemistry of the FeCl3-gallocyanine system has been investigated by pH titration, UV visible spectroscopy and M{\"o}ssbauer spectroscopy. Iron reduction was found in the pH range 2-5 and photo-reduction of the iron(III) present was also noted. Due to the instability of the species present in solution, the use of gallocyanine as a spectrophotometric indicator in iron systems is not encouraged. The iron-gallocyanine system was proposed as a potential model of the photosensitive anti-cancer drug, Bleomycin.",

author = "Douglas, {Kenneth T.} and Brendan Howlin and Jack Silver",

year = "1984",

month = jun,

doi = "10.1016/S0020-1693(00)80010-9",

language = "English",

volume = "92",

pages = "135--140",

journal = "Inorganica Chimica Acta",

issn = "0020-1693",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Solution chemistry and Mössbauer study of iron(II) and iron(III) complexes from gallocyanine

AU - Douglas, Kenneth T.

AU - Howlin, Brendan

AU - Silver, Jack

PY - 1984/6

Y1 - 1984/6

N2 - The iron solution chemistry of the FeCl3-gallocyanine system has been investigated by pH titration, UV visible spectroscopy and Mössbauer spectroscopy. Iron reduction was found in the pH range 2-5 and photo-reduction of the iron(III) present was also noted. Due to the instability of the species present in solution, the use of gallocyanine as a spectrophotometric indicator in iron systems is not encouraged. The iron-gallocyanine system was proposed as a potential model of the photosensitive anti-cancer drug, Bleomycin.

AB - The iron solution chemistry of the FeCl3-gallocyanine system has been investigated by pH titration, UV visible spectroscopy and Mössbauer spectroscopy. Iron reduction was found in the pH range 2-5 and photo-reduction of the iron(III) present was also noted. Due to the instability of the species present in solution, the use of gallocyanine as a spectrophotometric indicator in iron systems is not encouraged. The iron-gallocyanine system was proposed as a potential model of the photosensitive anti-cancer drug, Bleomycin.

UR - http://www.scopus.com/inward/record.url?scp=48549112498&partnerID=8YFLogxK

U2 - 10.1016/S0020-1693(00)80010-9

DO - 10.1016/S0020-1693(00)80010-9

M3 - Article

AN - SCOPUS:48549112498

SN - 0020-1693

VL - 92

SP - 135

EP - 140

JO - Inorganica Chimica Acta

JF - Inorganica Chimica Acta

IS - 2

ER -

Solution chemistry and Mössbauer study of iron(II) and iron(III) complexes from gallocyanine

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this